Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice

Infection and Immunity

Volumn 70, Issue 11, 2002, Pages 6068-6074

  Agelaki, Sofia ^a   Tsatsanis, Christos ^a   Gravanis, Achille ^a   Margioris, Andrew N ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTALARMIN; COMPLEMENTARY DNA; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; LD 50; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPTIC SHOCK; SURVIVAL RATE;

ANIMALS; CELL LINE; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; CYTOKINES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LETHAL DOSE 50; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; PITUITARY-ADRENAL SYSTEM; PYRIMIDINES; PYRROLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SHOCK, SEPTIC;

EID: 0036839613     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.11.6068-6074.2002     Document Type: Article

References (36)

1. Abraham, E., R. Wunderink, H. Silverman, T. M. Perl, S. Nasraway, H. Levy, R. Bone, R. P. Wenzel, R. Balk, R. Allred, et al. 1995. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. JAMA 273:934-941.
2. Audhya, T., R. Jain, and C. S. Hollander. 1991. Receptor-mediated immunomodulation by corticotropin-releasing factor. Cell Immunol. 134:77-84.
3. Baigent, S. M., and P. J. Lowry. 2000. mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J. Mol. Endocrinol. 25:43-52.
4. Becquet, D., F. Guillaumond, O. Bosler, and A. M. Francois-Bellan. 2001. Long-term variations of AP-1 composition after CRH stimulation: consequence on POMC gene regulation. Mol. Cell Endocrinol. 175:93-100.
5. Berkenbosch, F., J. van Oers, A. del Rey, F. Tilders, and H. Besedovsky. 1987. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238:524-526.
6. Bornstein, S. R., E. L. Webster, D. J. Torpy, S. J. Richman, N. Mitsiades, M. Igel, D. B. Lewis, K. C. Rice, H. G. Joost, M. Tsokos, and G. P. Chrousos. 1998. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. Endocrinology 139:1546-1555.
7. Carlo, E., I. M. Rosenberg, S. L. Brandwein, P. L. Beck, H. C. Reinecker, and D. K. Podolsky. 2000. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol. 164:966-972.
8. Crofford, L. J., H. Sano, K. Karalis, T. C. Friedman, H. R. Epps, E. F. Remmers, P. Mathern, G. P. Chrousos, and R. L. Wilder. 1993. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and esteoarthritis. J. Immunol. 151:1587-1596.
9. Crofford, L. J., H. Sano, K. Karalis, E. L. Webster, E. A. Goldmuntz, G. P. Chrousos, and R. L. Wilder. 1992. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J. Clin. Investig. 90:2555-2564.
10. Deak, T., K. T. Nguyen, A. L. Ehrlich, L. R. Watkins, R. L. Spencer, S. F. Maier, J. Licinio, M. L. Wong, G. P. Chrousos, E. Webster, and P. W. Gold. 1999. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 140:79-86.
11. Dermitzaki, E., C. Tsatsanis, A. Gravanis, and A. N. Margioris. 2002. Corticotropin-releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase. J. Biol. Chem. 277:12280-12287.
12. Dumitru, C. D., J. D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis, J. H. Lin, C. Patriotis, N. A. Jenkins, N. G. Copeland, G. Kollias, and P. N. Tsichlis. 2000. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tp12/ERK-dependent pathway. Cell 103:1071-1083.
13. Elenkov, I. J., and G. P. Chrousos. 1999. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol. Metab. 10:359-368.
14. Elenkov, I. J., E. L. Webster, D. J. Torpy, and G. P. Chrousos., 1999. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann. N. Y. Acad. Sci. 876:1-13.
15. Karalis, K., H. Sano, J. Redwine, S. Listwak, R. L. Wilder, and G. P. Chrousos. 1991. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254:421-423.
16. Kawahito, Y., H. Sano, S. Mukai, K. Asai, S. Kimura, Y. Yamamura, H. Kato, G. P. Chrousos, R. L. Wilder, and M. Kondo. 1995. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut 37:544-551.
17. Lumpkin, M. D. 1987. The regulation of ACTH secretion by IL-1. Science 238:452-454.
18. Makrigiannakis, A., A. N. Margioris, E. Zoumakis, C. Stournaras, and A. Gravanis. 1999. The transcription of corticotropin-releasing hormone in human endometrial cells is regulated by cytokines. Neuroendocrinology 70:451-459.
19. Mousa, S. A., M. Schafer, W. M. Mitchell, A. H. Hassan, and C. Stein. 1996. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur. J. Pharmacol. 311:221-231.
20. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397-1411.
21. Perrin, M. H., and W. W. Vale. 1999. Corticotropin releasing factor receptors and their ligand family. Ann. N. Y. Acad. Sci. 885:312-328.
22. Radulovic, M., F. M. Dautzenberg, S. Sydow, J. Radulovic, and J. Spiess. 1999. Corticotropin-releasing factor receptor 1 in mouse spleen: expression after immune stimulation and identification of receptor-bearing cells. J. Immunol. 162:3013-3021.
23. Sapolsky, R., C. Rivier, G. Yamamoto, P. Plotsky, and W. Vale. 1987. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238:522-524.
24. Singh, V. K., and H. H. Fudenberg. 1988. Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease. Immunol. Lett. 18:5-8.
25. Theoharides, T. C., L. K. Singh, W. Boucher, X. Pang, R. Letourneau, E. Webster, and G. Chrousos. 1998. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology. 139:403-413.
26. van der Bruggen, T., S. Nijenhuis, E. van Raaij, J. Verhoef, and B. S. van Asbeck. 1999. Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infect. Immun. 67:3824-3829.
27. Vasselon, T., and P. A. Detmers. 2002. Toll receptors: a central element in innate immune responses. Infect. Immun. 70:1033-1041.
28. Venihaki, M., P. Dikkes, A. Carrigan, and K. P. Karalis. 2001. Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J. Clin. Investig. 108:1159-1166.
29. Venihaki, M., A. Gravanis, and A. N. Margioris. 1997. Comparative study between normal rat chromaffin and PC12 rat pheochromocytoma cells: production and effects of corticotropin-releasing hormone. Endocrinology 138:698-704.
30. Venihaki, M., A. Gravanis, and A. N. Margioris, 1998. KAT45 human pheochromocytoma cell line. A new model for the in vitro study of neuroimmuno-hormonal interactions. Ann. N. Y. Acad. Sci. 840:425-433.
31. Waeber, G., N. Thompson, T. Chautard, M. Steinmann, P. Nicod, F. P. Pralong, T. Calandra, and R. C. Gaillard. 1998. Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3′, 5′-monophosphate responsive element-binding protein CREB in pituitary cells. Mol. Endocrinol. 12; 698-705.
32. Webster, E. L., D. B. Lewis, D. J. Torpy, E. K. Zachman, K. C. Rice, and G. P. Chrousos. 1996. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137:5747-5750.
33. Webster, E. L., D. J. Torpy, I. J. Elenkov, and G. P. Chrousos, 1998. Corticotropin-releasing hormone and inflammation. Ann. N. Y. Acad. Sci. 840:21-32.
34. Webster, E. L., D. E. Tracey, M. A. Jutila, S. A. Wolfe, Jr., and E. B. De Souza. 1990. Corticotropin-releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages. Endocrinology 127:440-452.
35. Wong, M. L., E. L. Webster, H. Spokes, P. Phu, M. Ehrhart-Bornstein, S. Bornstein, C. S. Park, K. C. Rice, G. P. Chrousos, J. Licinio, and P. W. Gold. 1999. Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. Life Sci. 65:L53-L58.
36. Zoumakis, E., E. Chatzaki, I. Charalampopoulos, A. N. Margioris, E. Angelakis, E. Koumantakis, and A. Gravanis. 2001. Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries. Gynecol. Endocrinol. 15:98-102.